Figure 6

Impact of GSH depletion or supplementation on ASFV replication in PAMs (MOI = 1). (A and B) cp204l levels, (C) p30 levels, and (D) viral titers at 12 and 24 hpi under various concentrations of BSO treatments. (E and F) cp204l levels, (G) p30 levels, and (H) viral titers at 12 and 24 hpi under various concentrations of NAC treatments.